Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Product Officer
-
Issuer Symbol
-
BBNX on Nasdaq
Mike Mensinger - trading volume in the past year for Beta Bionics, Inc.
Holdings reported by Mike Mensinger for Beta Bionics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
80,752 |
$2,430,675 |
$30.10 |
06 Jan 2026 |
Direct |
|
|
| Employee Stock Option (right to buy) |
52,000 |
|
|
27 Feb 2025 |
Direct |
Common Stock |
|
| Class B Common Stock Warrant (right to buy) |
0 |
|
|
31 Jan 2025 |
Direct |
Common Stock |
|
| Series D Preferred Stock |
0 |
|
|
31 Jan 2025 |
Direct |
Common Stock |
|
Transactions reported by Mike Mensinger for Beta Bionics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.